This study seeks the validation of a clinically useful brief screening and assessment instrument to identify patients with problematic substance use or a SUD to facilitate brief interventions and referrals to appropriate treatment. Specifically, this study’s aims to 1) develop a two-stage brief screening and assessment instrument to detect unhealthy use of tobacco, alcohol, prescription, and illicit drugs among primary care patients; 2) examine the validity of this 2-stage instrument by comparing it to reference standard measures for substance use, problematic use, and substance use disorders; and 3) determine the feasibility of a self-administered 2-stage tool and an interviewer-administered 2-stage tool in US General Medical Settings.
Principal Investigator(s)
Robert Schwartz , M.D.
1040 Park Avenue, Suite 103
Baltimore, MD 21201
United States
Jennifer McNeely, M.D., M.S.
180 Madison Avenue, 17th Floor
New York, NY 10016
United States
Li-Tzy Wu, Sc.D., R.N., M.A.
BOX 3903
Durham, NC 27710
United States
Participating Sites
- Chase Brexton Health Services, Maryland
- Virginia Commonwealth University, Institute for Drug and Alcohol Studies, Virginia
- Bellevue Primary Care, NYU School of Medicine, Department of Population Health, New York
- Cabarrus Health Alliance, North Carolina
- Novant Kannapolis Family Medicine, North Carolina